Authors:
ABDELRAHMAN SZ
ANWAR WA
ABDELAAL WE
MOSTAFA HM
AU WW
Citation: Sz. Abdelrahman et al., GSTM1 AND GSTT1 GENES ARE POTENTIAL RISK MODIFIERS FOR BLADDER-CANCER, Cancer detection and prevention, 22(2), 1998, pp. 129-138
Authors:
ABDELRAHMAN SZ
ANWAR WA
ABDELAAL WE
GHONEIM MA
AU WW
Citation: Sz. Abdelrahman et al., THE CYP2D6 EXTENSIVE METABOLIZER GENOTYPE IS ASSOCIATED WITH INCREASED RISK FOR BLADDER-CANCER, Cancer letters, 119(1), 1997, pp. 115-122
Citation: Sz. Abdelrahman et al., A MULTIPLEX PCR PROCEDURE FOR POLYMORPHIC ANALYSIS OF GSTM1 AND GSTT1GENES IN POPULATION STUDIES, Cancer letters, 107(2), 1996, pp. 229-233
Authors:
ANWAR WA
ABDELRAHMAN SZ
ELZEIN RA
MOSTAFA HM
AU WW
Citation: Wa. Anwar et al., GENETIC-POLYMORPHISM OF GSTM1, CYP2E1 AND CYP2D6 IN EGYPTIAN BLADDER-CANCER PATIENTS, Carcinogenesis, 17(9), 1996, pp. 1923-1929
Citation: Wa. Anwar et My. Shamy, CHROMOSOMAL-ABERRATIONS AND MICRONUCLEI IN REINFORCED-PLASTICS WORKERS EXPOSED TO STYRENE, Mutation research, 327(1-2), 1995, pp. 41-47
Authors:
ANWAR WA
SALAMA SI
ELSERAFY MM
HEMIDA SA
HAFEZ AS
Citation: Wa. Anwar et al., CHROMOSOMAL-ABERRATIONS AND MICRONUCLEUS FREQUENCY IN NURSES OCCUPATIONALLY EXPOSED TO CYTOTOXIC DRUGS, Mutagenesis, 9(4), 1994, pp. 315-317
Citation: Wa. Anwar, ASSESSMENT OF CYTOGENETIC CHANGES IN HUMAN-POPULATIONS AT RISK IN EGYPT, Mutation research. Section on environmental mutagenesis and related subjects, 313(2-3), 1994, pp. 183-191
Citation: Wa. Anwar, MONITORING OF HUMAN-POPULATIONS AT RISK BY DIFFERENT CYTOGENETIC END-POINTS, Environmental health perspectives, 102, 1994, pp. 131-134
Citation: Wa. Anwar et al., MICRONUCLEI, CHROMOSOMAL-ABERRATIONS AND AFLATOXIN-ALBUMIN ADDUCTS INEXPERIMENTAL-ANIMALS AFTER EXPOSURE TO AFLATOXIN B-1, MUTATION RESEARCH, 322(1), 1994, pp. 61-67
Citation: Wa. Anwar et Cp. Wild, THE PAN-AFRICAN-ENVIRONMENTAL-MUTAGEN-SOCIETY, REPORT ON INAUGURAL MEETING - MYCOTOXINS AS MUTAGENS AND CARCINOGENS - POSSIBILITIES FOR DISEASE PREVENTION, CAIRO, EGYPT, 23-26 JANUARY 1993, MUTATION RESEARCH, 312(1), 1994, pp. 61-63
Citation: Wa. Anwar, PRAZIQUANTEL (ANTISCHISTOSOMAL DRUG) - IS IT CLASTOGENIC, COCLASTOGENIC OR ANTICLASTOGENIC, MUTATION RESEARCH, 305(2), 1994, pp. 165-173
Citation: Mp. Rosin et al., INVOLVEMENT OF INFLAMMATORY REACTIONS AND ELEVATED CELL-PROLIFERATIONIN THE DEVELOPMENT OF BLADDER-CANCER IN SCHISTOSOMIASIS PATIENTS, MUTATION RESEARCH, 305(2), 1994, pp. 283-292
Citation: Mp. Rosin et al., INFLAMMATION, CHROMOSOMAL INSTABILITY, AND CANCER - THE SCHISTOSOMIASIS MODEL, Cancer research, 54(7), 1994, pp. 190001929-190001933